On the bad day this might turn out to be a lifeline : AcelRx Pharmaceuticals, Inc. (ACRX)

Price Performance of AcelRx Pharmaceuticals, Inc. (ACRX)

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) has experienced an interesting year when it comes to its price journey. This particular company’s stock managed to reach its 1-Year High price of $5.05 on 11/02/18, but it rose to its lowest point in the past year, $1.65 on 03/07/18.

At the end of the most recent trading day, AcelRx Pharmaceuticals, Inc. closed at $2.61. The stock began the trading session at $2.65 and hit a high of $2.78. The lowest price during the trading day was $2.6.

The shares of this company, which operates in the healthcare sector, reached a trading volume of about 1,335,662 throughout the day, which was clearly lower than the average daily volume for these shares.

At the time of writing, this publicly-traded organization holds a total market value of 201.91M, with 57 employees on its payroll.

Continuing forward, if we take into consideration what stock market experts are currently saying regarding AcelRx Pharmaceuticals, Inc.(NASDAQ:ACRX), the mean rating for this stock is 2.00. How is that calculated? Well, 2 analysts have given this company a BUY rating, 4 are rated it as OUTPERFORM, 2 have recommended that investors HOLD, 0 are considering it an UNDERPERFORM and 0 have recommended that owners of these shares SELL.

A month ago, 1 analysts thought this stock was a BUY, 4 of them posted an OUTPERFORM rating, 3 analysts recommended to HOLD this stock, 0 of them provided an underperform rating and 0 rated it as a Sell.

For ACRX stock, the reported Earnings Per Share trailing twelve months is sitting at 61.00%. Meanwhile, operating margin is currently observed to be and its Gross Margin trailing twelve months is -62.40%.

Technical analysis

This company’s 100-day moving average was 3.31, while its price change was posted at -0.49. Similarly, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) experienced a 100-day Percent movement of -15.81% with a trading volume reaching 2,989,777.

Continuing to look at similarly important data, this stock’s distance from its 200-day Simple Moving Average, or SMA 200, is -16.84% at the time of writing. This organization’s revenue over the trailing twelve months (TTM) of active operations is 2.30M, considering the fact that it was able to rack up the income of -$10.40M through that period of time.

While maintaining our attention on the Technical analysis of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), during the last 50 days, its Raw Stochastic average was observed 20.26%, representing a downgrade from this organization’s 20-day Raw Stochastic average – which was posted 59.05%. During the last 20-days time span, this firm’s Stochastic %K was 57.82% and its Stochastic %D was noted 55.74%.

When looking deeper into the past price path that shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) have taken, we can observe multiple moving trends. This particular stock’s current year-to-date (YTD) price performance is standing at 12.99%. Meanwhile, during the past six months of trading, this stock has deteriorated to -23.24%, along with a full-year performance of 18.64%. This company’s shares increased nearly 14.01% during the last 7-day stretch and up -4.74% over the last 30 days.